EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants

Mario Biglietto iD, Silvia Sorella, Erminia Baldacci, Massimo Breccia, Sabina Chiaretti, Marcello Capriata, Livia Donzelli, Gianna Maria D'Elia, Salvatore Giacomo Morano, Ilaria Del Giudice, Maurizio Martelli, Cristina Santoro und 1 weitere

European Journal of Haematology · 2026-12 · 117 (6) · 1421-1441

DOI: 10.1111/ejh.70262 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Haematology, online erschienen am 03.08.2026. Verfasst von Mario Biglietto und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Venous Thromboembolism, Anticoagulants. Die Arbeit nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thrombotic events, particularly venous thromboembolism (VTE), are a significant source of morbidity and mortality among patients with hematologic malignancies. These patients face unique challenges due to treatment‐related complications such as thrombocytopenia, coagulopathy, and heightened bleeding risk. Traditionally managed with low molecular weight heparin (LMWH), the advent of direct oral anticoagulants (DOACs) has introduced new opportunities for both prophylaxis and treatment of cancer‐associated thrombosis (CAT). This narrative review explores the disease‐specific thrombotic risk across hematologic malignancies and critically evaluates the current evidence supporting the use of DOACs in this setting. While emerging data suggest DOACs are effective and safe for VTE treatment and secondary prophylaxis, although with a higher incidence of clinically relevant non‐major bleeding in some studies, their role in primary prophylaxis remains under investigation and is currently limited by insufficient disease‐specific data. Laboratory monitoring may be warranted in the presence of anti‐cancer treatment‐DOACs interactions or unexpected clinical events. The utility of DOACs is particularly constrained in thrombocytopenic patients, where bleeding risks are heightened and evidence remains limited. Overall, this review highlights the need for robust, prospective, disease‐specific trials to define optimal anticoagulation strategies in oncohematologic patients and refine clinical decision‐making in this complex and high‐risk population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsVenous ThromboembolismAnticoagulantsHumansRisk FactorsIncidenceAdministration, OralHemorrhage

Stichwörter der Autor:innen

anticoagulation treatmentcancer associated thrombosishematological malignancyoral anticoagulantthrombotic riskvenous thromboembolism

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.

ORCID-Profile: Mario Biglietto, Antonio Chistolini

Zitieren

APA

Biglietto, M., Sorella, S., Baldacci, E., Breccia, M., Chiaretti, S., Capriata, M., Donzelli, L., D'Elia, G. M., Morano, S. G., Del Giudice, I., Martelli, M., Santoro, C., & Chistolini, A. (2026). Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants. European Journal of Haematology, 117(6), 1421-1441. https://doi.org/10.1111/ejh.70262

Vancouver

Biglietto M, Sorella S, Baldacci E, Breccia M, Chiaretti S, Capriata M, et al. Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants. European Journal of Haematology. 2026;117(6):1421-1441. doi:10.1111/ejh.70262

BibTeX
@article{Biglietto2026,
  author = {Biglietto, Mario and Sorella, Silvia and Baldacci, Erminia and Breccia, Massimo and Chiaretti, Sabina and Capriata, Marcello and Donzelli, Livia and D'Elia, Gianna Maria and Morano, Salvatore Giacomo and Del Giudice, Ilaria and Martelli, Maurizio and Santoro, Cristina and Chistolini, Antonio},
  title = {Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants},
  journal = {European Journal of Haematology},
  year = {2026},
  volume = {117},
  number = {6},
  pages = {1421--1441},
  doi = {10.1111/ejh.70262}
}
Kostenlos starten →